In 2023, there were an estimated 44 thousand total incident cases of kidney transplants across the 7MM, with the number ...

Both small animal models and microphysiological systems gain in sophistication and value as they expedite in vivo preclinical testing.

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2 A phase II trial has recently been ...

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where ...

Abs make up one of the most important classes of advanced biotherapies. GEN interviewed leaders about current challenges and ...

The Global Monoclonal Antibody Therapeutics Market is valued at approximately USD 205.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 15.0% over the forecast ...

Ray Lambert discusses humanized FcRn mice and their role in evaluating the pharmacokinetics of mAbs. Due to their extraordinary specificity and pharmacokinetic (PK) behavior, human immunoglobulin ...

WILMINGTON, Del., June 03, 2025--Multiple Incyte Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted at EHA 2025 ...

Chemistry and Pharmacology. Omalizumab, a recombinant DNA-derived humanized monoclonal antibody, binds to the Cε3 domain of IgE and forms complexes that inhibit the immune system's response to ...

The Company's oncology pipeline includes CM24, NT219, and CAPTN-3. CM24 is a humanized monoclonal antibody that blocks CEACAM1, which supports tumor immune evasion and survival through multiple ...